SI1140090T1 - Use of phanquinone for the treatment or prevention of memory impairment - Google Patents
Use of phanquinone for the treatment or prevention of memory impairmentInfo
- Publication number
- SI1140090T1 SI1140090T1 SI200030621T SI200030621T SI1140090T1 SI 1140090 T1 SI1140090 T1 SI 1140090T1 SI 200030621 T SI200030621 T SI 200030621T SI 200030621 T SI200030621 T SI 200030621T SI 1140090 T1 SI1140090 T1 SI 1140090T1
- Authority
- SI
- Slovenia
- Prior art keywords
- phanquinone
- prevention
- treatment
- memory impairment
- impairment
- Prior art date
Links
- 206010027175 memory impairment Diseases 0.000 title 1
- 229960003606 phanquinone Drugs 0.000 title 1
- VLPADTBFADIFKG-UHFFFAOYSA-N phanquone Chemical compound C1=CN=C2C(=O)C(=O)C3=NC=CC=C3C2=C1 VLPADTBFADIFKG-UHFFFAOYSA-N 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR99100005 | 1999-01-07 | ||
| PCT/IB2000/000011 WO2000040244A1 (en) | 1999-01-07 | 2000-01-06 | Use of phanquinone for the treatment or prevention of memory impairment |
| EP00900025A EP1140090B1 (en) | 1999-01-07 | 2000-01-06 | Use of phanquinone for the treatment or prevention of memory impairment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1140090T1 true SI1140090T1 (en) | 2005-06-30 |
Family
ID=10943706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200030621T SI1140090T1 (en) | 1999-01-07 | 2000-01-06 | Use of phanquinone for the treatment or prevention of memory impairment |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7030136B2 (pt) |
| EP (1) | EP1140090B1 (pt) |
| JP (1) | JP2002534386A (pt) |
| AR (1) | AR022215A1 (pt) |
| AT (1) | ATE285235T1 (pt) |
| AU (1) | AU1792200A (pt) |
| BR (1) | BR0008241A (pt) |
| CA (1) | CA2358487C (pt) |
| DE (1) | DE60016892T2 (pt) |
| DK (1) | DK1140090T3 (pt) |
| ES (1) | ES2234559T3 (pt) |
| HK (1) | HK1042039B (pt) |
| IL (1) | IL143903A (pt) |
| PT (1) | PT1140090E (pt) |
| SI (1) | SI1140090T1 (pt) |
| TR (1) | TR200101892T2 (pt) |
| WO (1) | WO2000040244A1 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU741782B2 (en) | 1997-08-21 | 2001-12-06 | P.N. Gerolymatos S.A. | Use of phanquinone for the treatment of Alzheimer's disease |
| AU2001250573A1 (en) * | 2000-04-28 | 2001-11-12 | Michel Xilinas | Treatment of pathological conditions influenced by the action of matrix metalloproteinases (mmps) using phanquinone |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1472257A (en) | 1973-09-10 | 1977-05-04 | Christiaens Sa A | Derivative of 4-hydroxy-5-azacoumarin |
| DK662687A (da) * | 1986-12-17 | 1988-06-18 | Glaxo Group Ltd | Anvendelse af tricycliske carbazoloner |
| US5091391A (en) * | 1990-08-16 | 1992-02-25 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Method of resisting neurodegenerative disorders |
| EP0613560B2 (en) | 1991-11-12 | 2006-06-21 | Prana Biotechnology Ltd | A method for assaying and treating alzheimer's disease |
| US5866597A (en) * | 1993-03-19 | 1999-02-02 | Glaxo Wellcome Inc. | Use of triazine compounds for the treatment of memory and learning disorders |
| US5792774A (en) * | 1996-02-21 | 1998-08-11 | Chiroscience Limited | Quinolones and their therapeutic use |
| AU1153097A (en) | 1996-06-07 | 1998-01-05 | Eisai Co. Ltd. | Stable polymorphs of donepezil (1-benzyl-4-{(5,6-dimethoxy-1-indanon)-2-yl}methylpiperidine ) hydrochloride and process for production |
| EP0959888B1 (en) * | 1996-08-13 | 2001-09-05 | P.N. Gerolymatos S.A. | Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease |
| WO1998040071A1 (en) | 1997-03-11 | 1998-09-17 | The General Hospital Corporation | Identification of agents for use in the treatment of alzheimer's disease |
| AU741782B2 (en) * | 1997-08-21 | 2001-12-06 | P.N. Gerolymatos S.A. | Use of phanquinone for the treatment of Alzheimer's disease |
| US5980914A (en) * | 1997-08-22 | 1999-11-09 | P.N. Gerolymatos S.A. | Clioquinol for the treatment of Parkinson's disease |
| US5994323A (en) * | 1997-12-31 | 1999-11-30 | P.N. Gerolymatos S.A. | Pharmaceutical compositions comprising clioquinol in combination with vitamin B12 and therapeutic and prophylactic uses thereof |
-
2000
- 2000-01-06 AU AU17922/00A patent/AU1792200A/en not_active Abandoned
- 2000-01-06 ES ES00900025T patent/ES2234559T3/es not_active Expired - Lifetime
- 2000-01-06 CA CA002358487A patent/CA2358487C/en not_active Expired - Fee Related
- 2000-01-06 BR BR0008241-4A patent/BR0008241A/pt not_active Application Discontinuation
- 2000-01-06 EP EP00900025A patent/EP1140090B1/en not_active Expired - Lifetime
- 2000-01-06 AT AT00900025T patent/ATE285235T1/de not_active IP Right Cessation
- 2000-01-06 WO PCT/IB2000/000011 patent/WO2000040244A1/en not_active Application Discontinuation
- 2000-01-06 JP JP2000592001A patent/JP2002534386A/ja active Pending
- 2000-01-06 SI SI200030621T patent/SI1140090T1/xx unknown
- 2000-01-06 IL IL14390300A patent/IL143903A/en not_active IP Right Cessation
- 2000-01-06 AR ARP000100046A patent/AR022215A1/es unknown
- 2000-01-06 DK DK00900025T patent/DK1140090T3/da active
- 2000-01-06 PT PT00900025T patent/PT1140090E/pt unknown
- 2000-01-06 DE DE60016892T patent/DE60016892T2/de not_active Expired - Fee Related
- 2000-01-06 TR TR2001/01892T patent/TR200101892T2/xx unknown
-
2002
- 2002-03-15 US US10/098,922 patent/US7030136B2/en not_active Expired - Fee Related
- 2002-04-10 HK HK02102678.3A patent/HK1042039B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US20030055078A1 (en) | 2003-03-20 |
| WO2000040244A1 (en) | 2000-07-13 |
| AU1792200A (en) | 2000-07-24 |
| AR022215A1 (es) | 2002-09-04 |
| DE60016892D1 (de) | 2005-01-27 |
| BR0008241A (pt) | 2001-10-30 |
| IL143903A0 (en) | 2002-04-21 |
| CA2358487C (en) | 2008-11-18 |
| CA2358487A1 (en) | 2000-07-13 |
| ES2234559T3 (es) | 2005-07-01 |
| HK1042039B (zh) | 2005-07-29 |
| IL143903A (en) | 2004-02-08 |
| JP2002534386A (ja) | 2002-10-15 |
| US7030136B2 (en) | 2006-04-18 |
| DE60016892T2 (de) | 2005-12-15 |
| HK1042039A1 (en) | 2002-08-02 |
| DK1140090T3 (da) | 2005-04-18 |
| PT1140090E (pt) | 2005-05-31 |
| ATE285235T1 (de) | 2005-01-15 |
| EP1140090B1 (en) | 2004-12-22 |
| EP1140090A1 (en) | 2001-10-10 |
| TR200101892T2 (tr) | 2001-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1047284A1 (en) | 2-amino-benzoxazinone derivatives for the treatment of obesity | |
| HK1161893A1 (zh) | 煤炭加工 | |
| IL146703A0 (en) | Dietary of pharmaceutical composition for use for the prevention or treatment of hyperoxaluria | |
| IL151890A0 (en) | Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain | |
| ZA200208228B (en) | Use of il-18 inhibitors for the treatment and/or prevention of athesclerosis | |
| IL151765A0 (en) | Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain | |
| IL151891A0 (en) | Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain | |
| HUP0302738A3 (en) | Use of sarp-1 for the treatment and/or prevention of scleroderma | |
| HU0003409D0 (en) | Treatment or prevention of coccidiosis | |
| IL143903A0 (en) | Use of phanquinone for the treatment or prevention of memory impairment | |
| GB9904252D0 (en) | Composition for the treatment of pain | |
| NZ514013A (en) | Treatment of hiatial hernia | |
| GB2359073B (en) | Fluid treatment | |
| GB0206401D0 (en) | Side effects treatment | |
| GB9926206D0 (en) | Anti-snoring treatment | |
| GB9921237D0 (en) | Fluid treatment | |
| SI1133290T1 (en) | Use of inhibitors of acetylcholinesterase for the treatment of deliriums | |
| GB9918000D0 (en) | Compositions for the treatment of pain | |
| GB9908993D0 (en) | Treatment | |
| EP1210077A4 (en) | COMPOSITION AND SYSTEMS FOR THE TREATMENT OF HYPERPIGMENTATION | |
| GB9917181D0 (en) | Methods of treatment | |
| GB9901310D0 (en) | Methods of treatment | |
| GB9906983D0 (en) | Fluid treatment | |
| GB9819590D0 (en) | Combination therapy for the treatment of aids | |
| GB9807938D0 (en) | Combination therapy for the treatment of AIDS |